Influence of pH, buffer, preservative, tonicity and viscosity modifiers on in vitro transcorneal permeation of ofloxacin was studied using excised goat cornea.
Introduction
Fluoroquinolones elicit their bactericidal response by inhibiting bacterial DNA gyrase and topoisomerase IV [1] . Fluoroquinolones possess excellent bactericidal activity against most frequently occurring gram+ve and gram-ve ocular pathogens [2] . As a result fluoroquinolones have carved their own niche in the topical management of ocular infections. Ofloxacin (0.3%, w/v) ophthalmic solution is official in USP [3] and is indicated in the treatment of conjunctivitis and keratoconjunctivitis. Intraocular penetration of ofloxacin has been found to be significantly greater than that of ciprofloxacin and norfloxacin [4] . Tear film levels of ofloxacin were found to be greater than MIC90 for a wide range of clinical isolates even 4 hours after the topical instillation [5] . Ofloxacin (0.3% w/v) ointment has been successfully employed in the management of ocular chlamydial infections [6] .
Earlier studies have demonstrated the enhancement of corneal penetration of ofloxacin by chitosan and its derivatives [7, 8] .
Topical delivery of drugs to the ocular tissues is affected by a complex interplay of biological, physiochemical and formulation factors. Formulators usually have to design a dosage form which provides a balance between corneal penetration, ocular irritation and formulation stability. Manipulation of formulation parameters to enhance the corneal penetration is one of the approaches of increasing ocular availability [9, 10] .There is very little information available on the effect of formulation parameters on the corneal permeation of ofloxacin. In the present study the effect of pH, buffer, tonicity modifier, viscosity modifier, preservative and stabilizers on the corneal permeation of ofloxacin was evaluated using freshly isolated goat cornea.
Results and Discussion
Tab.1 summarizes the effect of pH, buffer and tonicity modifiers on corneal permeation of ofloxacin. The average pH of tears is 7.2 and eyes can tolerate pH of 6.5-8.0 without much discomfort [9] . Ofloxacin yields a slightly turbid solution at Ofloxacin ophthalmic solution (0.3%, w/v) USP has a pH of 6.0-6.8. Increasing the pH of the formulation to physiological pH will reduce its irritation potential. So, in order to enhance the solubility of ofloxacin at pH 7.2, hydroxypropyl-β-cyclodextrin was employed. Cornea has an isoelectric point (pI) of 3.2, and above this pH, cornea is negatively charged, and thus becomes selectively permeable to cations [11] . Ofloxacin is a racemate with pKa 1 of 5.5 (for the carboxyl group), pKa 2 of 8.0(for the piperazinyl group) and pI of 6.75 [12] . Thus, increasing the pH of ofloxacin solution from 6.4 to 7.2 will increase the unionized fraction of ofloxacin, which should increase its corneal permeation. But the unionized drug concentration exceeds the solubility of drug in water at pH 7.2; as a result it gives a cloudy solution. Inclusion of cyclodextrin improved the solubility of drug at pH 7.2.
Cyclodextrins have earlier been reported to enhance [13] and dimnish [14] Significant difference compared to unbuffered formulation, † Significant difference compared to formulation containing sodium chloride as tonicity modifier. On comparing the corneal permeation of ofloxacin from different buffered vehicles, it was observed that there was a significant increase (P<0.05) in corneal permeation of ofloxacin from isotonic phosphate buffer compared with unbuffered vehicle, while citrate buffer had no effect on ofloxacin permeation.
The results also reveal that tonicity adjustment with sodium chloride provided maximum permeation of ofloxacin followed by glucose and mannitol. There was a significant decrease (P<0.05) in corneal permeation when mannitol was employed. Combination of MP and PP have been found to increase the corneal transport of insulin [15] and diclofenac [16] . BAC, a cationic surfactant has been reported to increase the corneal permeation of drugs by emulsification and disruption of corneal epithelium [17] . Combination of BAC and EDTA has been observed to increase the corneal permeation of fluoroquinolones like moxifloxacin [18] and gatifloxacin [19] .
Ofloxacin undergoes photochemical degradation [20] , so sodium metabisulphite (SMS), an antioxidant with small preservative action, and EDTA, a chelating agent were also evaluated for their effect on permeation. SMS has been found to enhance corneal transport of diclofenac [16] . EDTA [21] also has been found to increase the corneal permeation of drugs. However, in the present study, no significant change in corneal permeation of ofloxacin was observed with the use of SMS or EDTA. Table 3 shows the effect of viscosity modifier on corneal permeation of ofloxacin. Viscosity modifiers are used in eye drops to prolong the precorneal residence of drugs. The results show that there was no significant change in the corneal permeation of ofloxacin from formulations containing viscosity modifiers compared with control formulation containing no viscosity modifier. It is expected that during in vivo use polyvinyl alcohol (PVA) and methyl cellulose (MC) having higher viscosity will provide maximum precorneal residence. 
Tab. 3. Effect of viscosity modifiers on corneal permeation of ofloxacin

